1. Home
  2. FRMM vs CLNN Comparison

FRMM vs CLNN Comparison

Compare FRMM & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FRMM

Forum Markets Incorporated Common Stock

N/A

Current Price

$2.26

Market Cap

49.8M

Sector

Health Care

ML Signal

N/A

Logo Clene Inc.

CLNN

Clene Inc.

N/A

Current Price

$3.99

Market Cap

57.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FRMM
CLNN
Founded
N/A
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.8M
57.6M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
FRMM
CLNN
Price
$2.26
$3.99
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
$11.00
★ $32.20
AVG Volume (30 Days)
★ 146.1K
93.0K
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $6,547,000.00
$200,000.00
Revenue This Year
$177.58
$25.30
Revenue Next Year
$587.83
$9,184.04
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.76
$3.02
52 Week High
$7.15
$10.84

Technical Indicators

Market Signals
Indicator
FRMM
CLNN
Relative Strength Index (RSI) 25.62 51.19
Support Level $1.76 $3.78
Resistance Level $3.17 $4.05
Average True Range (ATR) 0.34 0.37
MACD -0.06 0.04
Stochastic Oscillator 7.41 30.19

Price Performance

Historical Comparison
FRMM
CLNN

About FRMM Forum Markets Incorporated Common Stock

Forum Markets Inc is a financial technology company focused on developing infrastructure that supports the origination, financing, and distribution of RWAs through blockchain-enabled capital markets. The company's business approach is centered on integrating traditional financial asset markets with blockchain-based infrastructure to enable the tokenization of income-generating real-world assets such as consumer credit, equipment finance assets, and other contractual cash-flow streams. It utilizes blockchain infrastructure, including Ethereum and related Layer-2 scaling protocols, to support the issuance, management, and potential secondary trading of tokenized financial instruments.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: